Preexisting CD4+ T-cell immunity in human population to avian influenza H7N9 virus: Whole proteome-wide immunoinformatics analyses

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Duvvuri, Venkata R ^a   Duvvuri, Bhargavi ^a   Alice, Christilda ^a   Wu, Gillian E ^a   Gubbay, Jonathan B ^b,c,d,e   Wu, Jianhong ^a  

^a YORK UNIVERSITY   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c PUBLIC HEALTH ONTARIO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA DRB1 ANTIGEN; PROTEOME; MEMBRANE PROTEIN;

ARTICLE; AUSTRALIA; CANADA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNICITY; HUMAN; IMMUNOGENICITY; INDIGENOUS PEOPLE; INFECTION RISK; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H2N2; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H7N9; MEXICO; NONHUMAN; PREDICTION; SEQUENCE HOMOLOGY; UNITED STATES; VIRUS IMMUNITY; ALLELE; ANIMAL; AVIAN INFLUENZA; BIOLOGY; BIRD; CHINA; ETHNIC GROUP; IMMUNOLOGY; METABOLISM; NUCLEOTIDE SEQUENCE; VIROLOGY;

ALLELES; ANIMALS; BIRDS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHINA; COMPUTATIONAL BIOLOGY; CONSERVED SEQUENCE; EPITOPES, T-LYMPHOCYTE; ETHNIC GROUPS; HUMANS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA IN BIRDS; MEMBRANE PROTEINS; PROTEOME; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84897374046     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091273     Document Type: Article

References (51)

1. World Health Organization. Background and summary of human infection with influenza A(H7N9) virus - as of 5 April 2013 Available: http://www.who.int/ influenza/human-animal-interface/update-20130405/en/ Accessed 2013 September 21.
2. Liu D, Shi W, Shi Y, Wang D, Xiao H, et al. (2013) Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses. Lancet 381:1926-32.
3. Li Q, Zhou L, Zhou M, Chen Z, Li F, et al. (2013) Preliminary Report: Epidemiology of the Avian Influenza A (H7N9) Outbreak in China. N Engl J Med "in press".
4. Yang S, Chen Y, Cui D, Yao H, Lou J, et al. (2014) Avian-Origin Influenza A(H7N9) Infection in Influenza A(H7N9)-Affected Areas of China: A Serological Study. J Infect Dis. 209:265-9.
5. Cheng VC, To KK, Tse H, Hung IF, Yuen KY (2012). Two years after pandemic influenza A/2009/H1N1: what have we learned? Clin Microbiol Rev 2:223-63.
6. Greenbaum JA, Kotturi MF, Kim Y, Oseroff C, Vaughan K, et al. (2009) Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci U SA 106: 20365-20370.
7. Duvvuri VR, Moghadas SM, Guo H, Duvvuri B, Heffernan JM, et al. (2010) Highly conserved cross-reactive CD4+ T-cell HA epitopes of seasonal and the 2009 pandemic influenza viruses. Influenza and other Respiratory Viruses 4: 249-258.
8. Duvvuri VR, Duvvuri B, Jamnik V, Gubbay JB, Wu J, et al. (2013) T cell memory to evolutionarily conserved and shared Hemagglutinin epitopes of H1N1 viruses: A pilot scale study. BMC infectious diseases, 13:204.
9. Wilkinson T, Li C, Chui C, Huang A, Perkins M, et al. (2012) Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med 18:274-280.
10. Weinfurter J, Brunner K, Capuano S, Li C, Broman K, et al. (2011) Cross-Reactive T Cells Are Involved in Rapid Clearance of Pandemic H1N1 Influenza Virus in Nonhuman Primates. PLoS Pathogen 7:e1002381.
11. McMichael AJ, Gotch FM, Noble GR, Beare PA (1983) Cytotoxic T-cell immunity to influenza. N Engl J Med 309:13-17. (Pubitemid 13062888)
12. Webby RJ, Andreansky S, Stambas J, Rehg JE, Webster RG, et a. (2003) Protection and compensation in the influenza virus-specific CD8+ T cell response. Proc Natl Acad Sci U SA 100:7235-7240. (Pubitemid 36706422)
13. McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, et al. (2006) T cell responses are better correlates of vaccine protection in the elderly. J Immunol 176: 6333-6339.
14. De Groot AS, Ardito M, McClaine EM, Moise L, Martin WD (2009) Immunoinformatic comparison of T-cell epitopes contained in novel swineorigin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine. Vaccine 27:5740-5747.
15. Richards KA, Topham D, Chaves FA, Sant AJ (2010) Cutting edge: CD4 T cells generated from encounter with seasonal influenza viruses and vaccines have broad protein specificity and can directly recognize naturally generated epitopes derived from the live pandemic H1N1 virus. J. Immunol 185: 4998-5002.
16. + T cells directed against H5N1 influenza virus. J. Immunol 180: 1758-1768.
17. Khan AM, Miotto O, Heiny AT, Salmon J, Srinivasan KN, et al. (2007) A systematic bioinformatics approach for selection of epitope-based vaccine targets. Cell Immunol 244: 141-147.
18. Heiny AT, Miotto O, Srinivasan KN, Khan AM, Zhang GL, et al. (2007) Evolutionarily Conserved Protein Sequences of Influenza A Viruses, Avian and Human, as Vaccine Targets. PLoS ONE 2(11): e1190.
19. Assarsson E, Bui HH, Sidney J, Zhang Q, Glenn J, et al. (2008) Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans. J Virol. 82:12241-51.
20. Katoh K, Standley DM (2013) MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol. 30:772-80.
21. Lin HH, Zhang GL, Tongchusak S, Reinherz EL, Brusic V (2008) Evaluation of MHCII peptide binding prediction servers: applications for vaccine research. BMC Bioinformatics (Suppl. 12):S22.
22. Bui HH, Sidney J, Li W, Fusseder N, Sette A (2007) Development of an epitope conservancy analysis tool to facilitate the design of epitopebased diagnostics and vaccines. BMC Bioinformatics 8: 361.
23. Duvvuri VR, Marchand-Austin A, Eshaghi A, Patel SN, Low DE, et al. (2012) Potential T cell epitopes within swine-origin triple reassortant influenza A (H3N2) variant virus which emerged in 2011: an immunoinformatics study. Vaccine. 30: 6054-63.
24. Vita R, Zarebski L, Greenbaum JA, Emami H, Hoof I, et al. (2010) The immune epitope database 2.0. Nucleic Acids Res. 38 (Database issue):D854-62.
25. Bui HH, Sidney J, Dinh K, Southwood S, Newman MJ, et al. (2006) Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics 7:153.
26. Quiñones-Parra S, Grant E, Loh L, Nguyen TH, Campbell KA, et al. (2014) Preexisting CD8+ T-cell immunity to the H7N9 influenza A virus varies across ethnicities. Proc Natl Acad Sci U S A. 2014 Jan 6.
27. Hertz T, Oshansky CM, Roddam PL, DeVincenzo JP, Caniza MA, et al. (2013) HLA targeting efficiency correlates with human T-cell response magnitude and with mortality from influenza A infection. Proc Natl Acad Sci U S A. 110:13492-7.
28. Kageyama T, Fujisaki S, Takashita E, Xu H, Yamada S, et al. (2013) Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. Euro Surveill. 18:20453.
29. Gao R, Cao B, Hu Y, Feng Z, Wang D, et al. (2013) Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med. 368:1888-97.
30. Qi X, Qian YH, Bao CJ, Guo XL, Cui LB, et al. (2013) Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation. BMJ. 347:f4752.
31. Zhu Y, Qi X, Cui L, Zhou M, Wang H (2013) Human co-infection with novel avian influenza A H7N9 and influenza A H3N2 viruses in Jiangsu province, China. Lancet. 381:2134.
32. Uyeki TM, Cox NJ (2013) Global concerns regarding novel influenza A (H7N9) virus infections. N Engl J Med. 368:1862-4.
33. Tuite AR, Greer AL, Whelan M, Winter AL, Lee B, et al. (2009)Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza. CMAJ. 182:131-136.
34. Reed C, Angulo FJ, Swerdlow DL, Lipsitch M, Meltzer MI, et al. (2009) Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerg Infect Dis, 15: 2004-2007.
35. De Groot AS, Ardito M, Terry F, Levitz L, Ross T, et al. (2013) Low immunogenicity predicted for emerging avian-origin H7N9: Implication for influenza vaccine design. Human Vaccines & Immunotherapeutics, 9(5): 950-956.
36. Galli G, Medini D, Borgogni E, Zedda L, Bardelli M, et al. (2009) Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels. Proc Natl Acad Sci USA 106: 3877-82.
37. La Ruche G, Tarantola A, Barboza P, Vaillant L, Gueguen J, et al. (2009) The 2009 pandemic H1N1 influenza and indigenous populations of the Americas and the Pacific. Euro Surveill, 14: 19366.
38. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, et al. (2009) Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA, 302:1872-1879.
39. Zarychanski R, Stuart TL, Kumar A, Doucette S, Elliott L, et al. (2010) Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ, 182(3):257-64.
40. Boggild AK, Yuan L, Low DE, McGeer AJ (2011) The impact of influenza on the Canadian First Nations. Can J Public Health, 102: 345-8.
41. Brooks EG, Bryce CH, Avery C, Smelser C, Thompson D, et al. (2012) 2009 H1N1 fatalities: the New Mexico experience. J Forensic Sci. 57: 1512-8.
42. Schaffer A, Muscatello D, Cretikos M, Gilmour R, Tobin S, et al. (2012) The impact of influenza A(H1N1)pdm09 compared with seasonal influenza on intensive care admissions in New South Wales, Australia, 2007 to 2010: a time series analysis. BMC Public Health. 12:869.
43. Lindstrom S, Garten R, Balish A, Shu B, Emery S, et al. (2012) Human infections with novel reassortant influenza A(H3N2)v viruses, United States, 2011. Emerg Infect Dis. 18:834-7.
44. Trauer JM, Bandaranayake D, Booy R, Chen MI, Cretikos M, et al. (2013) Seroepidemiologic effects of influenza A(H1N1)pdm09 in Australia, New Zealand, and Singapore. Emerg Infect Dis, 19: 92-101.
45. Ip DK, Liao Q, Wu P, Gao Z, Cao B, et al. (2013) Detection of mild to moderate influenza A/H7N9 infection by China's national sentinel surveillance system for influenza-like illness: case series. BMJ. 346:f3693.
46. Lv H, Han J, Zhang P, Lu Y, Wen D, et al. (2013) Mild illness in avian influenza A(H7N9) virus-infected poultry worker, Huzhou, China, April 2013. Emerg Infect Dis. 19(11):1885-8.
47. Ahlers JD, Takeshita T, Pendleton CD, Berzofsky JA (1997) Enhanced immunogenicity of HIV-1 vaccine construct by modification of the native peptide sequence. Proc Natl Acad Sci U S A, 94:10856-61. (Pubitemid 27430825)
48. + class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide. J Immunol, 148:894-9.
49. Ayyoub M, Merlo A, Hesdorffer CS, Speiser D, Rimoldi D, et al. (2005) Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2. Clin Immunol, 114:70-8. (Pubitemid 39642792)
50. Zwaveling S, Ferreira Mota SC, Nouta J, Johnson M, Lipford GB, et al. (2002) Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides. J Immunol, 169:350-8. (Pubitemid 34686155)
51. Karosiene E, Rasmussen M, Blicher T, Lund O, Buus S, et al. (2013) NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ. Immunogenetics, 65: 711-24.